Raphael Pharmaceutical Inc. (RAPH) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2024 | $19.0K | -91.7% |
| 2023 | $230.0K | -20.1% |
| 2022 | $288.0K | +88.2% |
| 2021 | $153.0K | +61.1% |
| 2020 | $95.0K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2024 | $19.0K | -91.7% |
| 2023 | $230.0K | -20.1% |
| 2022 | $288.0K | +88.2% |
| 2021 | $153.0K | +61.1% |
| 2020 | $95.0K | — |